Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 4/20 | 0.55 |
| ▸ | NT5E | P21589 | 1/20 | 0.55 |
| ▸ | STING1 | Q86WV6 | 3/20 | 0.55 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.55 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.55 |
| ▸ | GSK3A | P49840 | 2/20 | 0.52 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.52 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.52 |
| ▸ | PNP | P00491 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.51 |
| ▸ | KRAS | P01116 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL237754 | 0.84 | HINT1 (0.58) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL8199215 | 0.82 | HINT1 (0.53) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL2510562 | 0.82 | HINT1 (0.62) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL4278130 | 0.82 | HINT1 (0.62) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL19938159 | 0.82 | HINT1 (0.62) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL24299397 | 0.82 | HINT1 (0.62) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL11183383 | 0.82 | HINT1 (0.59) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL13833323 | 0.82 | HINT1 (0.62) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL16114092 | 0.82 | HINT1 (0.62) | HINT1NT5ESTING1PDE3BPDE3A | |
| SCHEMBL1120568 | 0.81 | HINT1 (0.59) | HINT1NT5ESTING1PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096203-A1 | TARGETING A CHIMERIC RNA FOR TREATING CANCER | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2024035952-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES | REMIX THERAPEUTICS INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| CN-114404581-A | Cancer vaccine | 摩登纳特斯有限公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-3169335-A2 | CIRCULAR POLYNUCLEOTIDES | Moderna Therapeutics, Inc. (US) | 2017-05-24 | — | — | EP | disclosed |
| EP-3041934-A1 | CHIMERIC POLYNUCLEOTIDES | Moderna Therapeutics, Inc. (US) | 2016-07-13 | — | — | EP | disclosed |
| WO-2016011222-A2 | CIRCULAR POLYNUCLEOTIDES | MODERNA THERAPEUTICS, INC. (US) | 2016-01-21 | — | — | WO | disclosed |
| WO-2015034928-A1 | CHIMERIC POLYNUCLEOTIDES | MODERNA THERAPEUTICS, INC. (US) | 2015-03-12 | — | — | WO | disclosed |